GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Mankind Pharma Ltd
Mankind Pharma Allots 49,112 ESOP Shares, Boosting Share Count
FUNDRAISE ● No Immediate Change LOW RISK
📅 Filed on BSE: 01 Sep 2026, 05:59 PM IST  ·  BSE ID: 582a1090-b148-43fb-a2a0-1c4a16cb1f20
View Original BSE Filing (PDF)
💡
In Simple Terms
Mankind Pharma issued new shares to employees who exercised stock options, increasing its total outstanding shares.
🤖 AI Summary
  • Mankind Pharma allotted 49,112 equity shares under its ESOP Plan 2022.
  • The allotment occurred on September 1, 2026, increasing total shares.
  • Each share has a face value of ₹1/-, with an exercise price of ₹860.00.
  • New shares are identical and rank pari-passu with existing equity shares.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of shares issued
49,112 Equity Shares
Face value per share
₹1/- per equity share
Exercise price per share
₹860.00/- per equity share
Premium per share
₹859.00/- per equity share
Total Issued shares after this issue
41,30,45,090
Total Issued share capital after this issue
₹ 41,30,45,090/-
🏢 How This Affects the Company
💰
Financial Impact
The company's paid-up share capital increased from 41,29,95,978 Equity Shares to 41,30,45,090 Equity Shares following the allotment.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this allotment.
👤
Who Is Affected
Shareholders are affected by a fractional increase in the total number of outstanding equity shares.
🔍
Management Signal
The allotment demonstrates management's commitment to employee incentives through the ESOP Plan 2022.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Quarterly results to track overall financial performance.
Future ESOP exercise disclosures for further share issuances.
Any announcements on dividend payouts or capital allocation.
LOW RISK Routine ESOP allotment; no new material risks introduced by this filing.
💡 Investor Takeaway
Mankind Pharma Limited has increased its issued share capital by 49,112 equity shares due to ESOP exercise, with shares ranking pari-passu.
⚖️ Strengths & Concerns

✅ Positives

  • Successful execution of ESOP plan to reward eligible employees with equity.
  • Total issued share capital now stands at 41,30,45,090 equity shares.
❓ Frequently Asked Questions
How many equity shares did Mankind Pharma allot under its ESOP Plan on September 1, 2026?
Mankind Pharma allotted 49,112 equity shares under the Mankind Employee Stock Option Plan 2022.
What is the total number of issued equity shares of Mankind Pharma after the ESOP allotment?
The total issued shares of Mankind Pharma after this issue is 41,30,45,090.
What is the face value and exercise price of the shares allotted by Mankind Pharma?
The shares have a face value of ₹1/- per equity share and an exercise price of ₹860.00/- per equity share.
Do the newly allotted shares rank differently from existing Mankind Pharma shares?
No, all equity shares allotted pursuant to exercise of options shall rank pari-passu with the existing equity shares of the Company.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.